81 FR 19975 - Endocrinologic and Metabolic Drugs Advisory Committee; Amendment of Notice

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 81, Issue 66 (April 6, 2016)

The Food and Drug Administration (FDA) is announcing an amendment to the notice of a meeting of the Endocrinologic and Metabolic Drugs Advisory Committee. This meeting was announced in the Federal Register of March 16, 2016. The amendment is being made to reflect a change in the Date and Time portion of the document. The Date of the meeting is changed to May 25, 2016. There are no other changes.

[Federal Register Volume 81, Number 66 (Wednesday, April 6, 2016)]
[Notices]
[Pages 19975-19976]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-07899]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-0001]


Endocrinologic and Metabolic Drugs Advisory Committee; Amendment 
of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an 
amendment to the notice of a meeting of the Endocrinologic and 
Metabolic Drugs Advisory Committee. This meeting was announced in the 
Federal Register of March 16, 2016. The amendment is being made to 
reflect a change in the Date and Time portion of the document. The Date 
of the meeting is changed to May 25, 2016. There are no other changes.

FOR FURTHER INFORMATION CONTACT: LaToya Bonner, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 31, Rm. 2417,

[[Page 19976]]

Silver Spring, MD 20993-0002, 301-796-9001, FAX: 301-847-8533, 
[email protected], or FDA Advisory Committee Information Line, 1-800-
741-8138 (301-443-0572 in the Washington, DC area). Please call the 
Information Line for up-to-date information on this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of March 16, 2016 
(81 FR 14115), FDA announced that a meeting of the Endocrinologic and 
Metabolic Drugs Advisory Committee would be held on May 24, 2016. On 
page 14115, in the second column, the Date and Time portion of the 
document is changed to read as follows:
    Date and Time: The meeting will be held on May 25, 2016, from 8 
a.m. to 5 p.m.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

    Dated: April 1, 2016.
Jill Hartzler Warner,
Associate Commissioner for Special Medical Programs.
[FR Doc. 2016-07899 Filed 4-5-16; 8:45 am]
BILLING CODE 4164-01-P